Denileukin Diftitox as Novel Targeted Therapy for Lymphoid Malignancies

By Wong Bryan   Gregory Stephanie   Dang Nam  

Cancer Investigation, Vol. 25, Iss. 6, 2007-09 ,pp. : 495-501

Informa Healthcare

Access to resources Recommend Favorite

A multicenter phase II trial to determine the safety and efficacy of combination therapy with denileukin diftitox and cyclophosphamide, doxorubicin, vincristine and prednisone in untreated peripheral T-cell lymphoma: the CONCEPT study

By Foss Francine M.  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1373-1379

Informa Healthcare

Access to resources Recommend Favorite

Optimizing Anthracycline Therapy for Node Positive Breast Cancer

By Cardoso F.   Atalay G.   Piccart M.J.  

American Journal of Cancer, Vol. 1, Iss. 4, 2002-01 ,pp. : 257-268

Adis International

Access to resources Recommend Favorite

Chronic Lymphocytic Leukemia: Strategies for Optimizing Therapy

By Cheze S.   Leporrier M.  

American Journal of Cancer, Vol. 1, Iss. 2, 2002-02 ,pp. : 127-143

Adis International

Access to resources Recommend Favorite

The role of hyperthermia in optimizing tumor response to regional therapy

By Moyer Hunter   Delman Keith  

International Journal of Hyperthermia, Vol. 24, Iss. 3, 2008-01 ,pp. : 251-261

Informa Healthcare

Access to resources Recommend Favorite